Journal of Cytokine Biology
Open Access

Barry Neun

Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA

Biography

Mr. Barry Neun is the primary technician responsible for endotoxin and sterility pre-screening of all materials submitted to the NCL.  He also functions as the Radiation Area Supervisor for the NCL Radiation Program.  As part of the Immunology Section, Barry performs various hematology and immunotoxicity assays, which further help characterize the submitted nanomaterial. 

Publications

Chemical Modification of CRISPR gRNAs Eliminate type I Interferon Responses in Human Peripheral Blood Mononuclear Cells

Objectives: CRISPR/Cas9 is currently the primary tool used for genome editing in mammalian cells. To cleave and alter genomic DNA, both the Cas9 nuclease and a guide RNA (gRNA) must be present in the nucleus. One preferred method of introducing these reagents is direct transfection of a recombinant Cas9 protein complexed with a synthetic gRNA as a ... Read More»

Mollie S. Schubert, Edward Cedrone, Barry Neun, Mark A. Behlke and Marina A. Dobrovolskaia

Case Report: J Cytokine Biol, 3: 121

DOI: 10.4172/2576-3881.1000121

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article